Related Experiment Video

Updated: Jun 15, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets

Samantha Gadd1, Simone Treiger Sredni, Chiang-Ching Huang

  • 1Department of Pathology, Northwestern University's Feinberg School of Medicine, Chicago, IL, USA.

Laboratory Investigation; a Journal of Technical Methods and Pathology
|March 10, 2010
PubMed

Insights

Loss of SMARCB1 in rhabdoid tumors (RT) disrupts neural development and cell cycle control, suggesting early progenitor cells are involved. This finding may reveal new therapeutic targets for aggressive RT.

Area of Science:

  • Oncology
  • Developmental Biology
  • Genetics

Background:

  • Rhabdoid tumors (RT) are aggressive pediatric cancers characterized by the genetic loss of SMARCB1 (SNF5, INI-1), a key component of the SWI/SNF chromatin remodeling complex.
  • Currently, no effective treatments exist for RT, highlighting an urgent need to understand their pathogenesis and identify therapeutic targets.

Purpose of the Study:

  • To investigate the SMARCB1-mediated pathogenesis of rhabdoid tumors.
  • To identify potential therapeutic targets for aggressive RT by analyzing global gene expression patterns.

Main Methods:

  • Global gene expression profiling was performed on 10 RT samples and compared with 12 cellular mesoblastic nephromas, 16 clear cell sarcomas of the kidney, and 15 Wilms tumors.
  • Gene Set Enrichment Analysis (GSEA) and immunohistochemistry were used to validate differential gene expression and protein marker status.

Main Results:

  • 114 top differentially expressed genes were identified in RT, including downregulation of SMARCB1 and associated genes.
  • A significant downregulation of genes involved in neural and neural crest development was observed, confirmed by GSEA and negative expression of stem cell markers (SOX10, ID3, CD133, Musashi).
  • Dysregulation of cell cycle inhibitors (CDKNs) and upregulation of MYC-C were noted, alongside altered expression of tumor suppressor and metastasis-associated genes (SPP1, COL18A1, PTPRK, DOCK4).

Conclusions:

  • Rhabdoid tumors likely arise from early progenitor cells during a critical developmental window.
  • Loss of SMARCB1 leads to repression of neural development, loss of cell cycle inhibition, and dysregulation of epigenetic modifiers (trithorax/polycomb).
  • These findings provide insights into RT pathogenesis and suggest potential therapeutic strategies targeting these pathways.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...